Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Diseases

Explore clinical trials studying Pancreatic Diseases. Study availability and eligibility vary by location and protocol.

4,387 public trials 842 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Diseases trial results

Completed

Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)

NCT01808638

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Ductal, +12 more
Locations
  • Charité - Universitätsmedizin Berlin Charité Centrum für Tumormedizin Berlin, Germany
  • Klinikum Dortmund gGmbH Medizinische Klinik Mitte Dortmund, Germany
  • Universitätsklinikum Freiburg, Innere Medizin II Freiburg im Breisgau, Germany
  • Medizinische Klinik III - Hämatologie/Onkologie Marienhospital Herne Herne, Germany
View Trial Details
Completed

A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer

NCT00383149

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +6 more
Locations
  • Georgetn Univ Lombardi Can Ctr Washington D.C., District of Columbia, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • University Of Miami Miami, Florida, United States
  • University Of Michigan Ann Arbor, Michigan, United States
View Trial Details
Completed

Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy

NCT01658943

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations
  • The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 534 locations
View Trial Details
Completed

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

NCT01433263

Conditions
Adenocarcinoma, Body Weight, Body Weight Changes, +26 more
Locations
  • Novartis Investigative Site Tucson, Arizona, United States
  • Novartis Investigative Site Tampa, Florida, United States
  • Novartis Investigative Site Chicago, Illinois, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
View Trial Details

Related conditions